ICD-10-PCS Billable Code

CG14YZZ

Planar Nuclear Medicine Imaging Adrenal Glands, Bilateral to None with None, Other Radionuclide Approach

Procedural Specifications

Clinical Axis Detail Definition
SectionC Nuclear Medicine
Body SystemG Endocrine System
Operation1 Planar Nuclear Medicine Imaging
Body Part4 Adrenal Glands, Bilateral
ApproachY Other Radionuclide
DeviceZ None
QualifierZ None

Operation Definition

Introduction of radioactive materials into the body for single plane display of images developed from the capture of radioactive emissions

Procedure Overview

This family describes single-plane radioactive imaging of endocrine glands, most often a thyroid scan and sometimes a parathyroid or adrenal scan. A small amount of radioactive iodine or technetium pertechnetate is swallowed or injected, the gland absorbs it in proportion to how active its cells are, and a gamma camera held in one or two fixed positions captures flat, two-dimensional pictures of the uptake pattern.

Physicians use this scan to tell apart different causes of an overactive thyroid, such as Graves' disease versus a single toxic nodule, to characterize a thyroid nodule found on ultrasound, or to look for residual or recurrent thyroid cancer tissue after surgery. A parathyroid version, usually done with a sestamibi tracer, helps locate an overactive parathyroid gland before surgery. The scan is painless and usually completed within an hour of the tracer being given, though thyroid studies sometimes require the patient to return for delayed images.

Anatomy & Axis Detail

Adrenal Glands, Bilateral

Paired small glands sitting atop each kidney, the adrenals produce catecholamines from their medulla and steroid hormones from their cortex, and imaging both sides together allows direct comparison of uptake between glands, which is central to distinguishing unilateral disease such as a pheochromocytoma or adenoma from bilateral hyperplasia. Agents like MIBG localize to catecholamine-storing medullary tissue, while cortical agents target steroid-producing tissue, so the choice of radiopharmaceutical depends heavily on the suspected pathology being cortical versus medullary. Because the glands are deep, small, and closely related to the kidneys, liver, and spleen, planar images require careful positioning and often delayed acquisitions to allow background clearance, and bilateral symmetry on the images itself becomes a key diagnostic clue when one side shows discordant uptake.

Radionuclide: Other Radionuclide

Other Radionuclide is used when a nuclear medicine study employs a radioactive tracer that does not correspond to one of the specifically named isotope values in this axis, such as an uncommon or newer radiopharmaceutical. It functions as a catch-all so the procedure can still be coded precisely by section and root operation even when the exact tracer lacks its own dedicated code value.

Coding & Documentation

Coding from this family depends on documentation showing that only flat, single-position images were acquired, without a rotational SPECT component. The report should identify the tracer, the gland imaged, and the camera views obtained. A frequent mistake is applying this code when the department actually performed a combined uptake-and-scan visit; the uptake measurement and the imaging are distinct root operations and both must be captured if both were done. Another recurring error is defaulting to "planar" because that is the more familiar term, when the technologist's protocol notes actually describe a SPECT acquisition.

Commonly Confused With

The closest look-alike is Tomographic Nuclear Medicine Imaging of the endocrine system, which differs only in whether the camera rotated to produce 3D reconstructions; dual-phase parathyroid protocols in particular are frequently planar-only despite reports that use the word "tomographic" loosely. It is also confused with Nonimaging Nuclear Medicine Uptake, which measures gland function as a percentage or count rate and produces no picture at all.